Novo Nordisk Faces Generic Competition for Weight-Loss Drugs

Despite a significant share price drop, Zealand Pharma's CEO remains optimistic, while Novo Nordisk anticipates competition from cheaper generic versions of its weight-loss drugs entering major markets this year.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

berlingskeDanish126d ago

Business-update: Billige Novo-kopier kan ramme store markeder i år

På trods af et stort kursfald er Zealand Pharma-topchef »sindssygt begejstret« og Novo Nordisk kan se frem til kopikonkurrence. Det er nogle af de historier, du får i fredagens Business-update.

Read full article →

PERSPECTA

PERSPECTA

Novo Nordisk Faces Generic Competition for Weight-Loss Drugs

Sources

Business-update: Billige Novo-kopier kan ramme store markeder i år

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

Meralco hikes rates on generation fees

Baguio City Rejects P1.27-B Hydropower Plant Bid

Filipino Nonprofit Receives Grant for Children's Heart Disease Program

PERSPECTA